Not Signed In - Downstate Researchers Target Multiple Sclerosis
Sun, 26 Nov 2006 05:00 AM EST
... Researchers at SUNY Downstate Medical Center have developed a substance that inhibits the progress of multiple sclerosis (MS) in an animal model. The agent, a novel calpain inhibitor, can be administered orally.Calpains are a family of proteolytic enzymes naturally found in the human body. [click link for full article] ...
Related Topics
- Multiple Sclerosis/ms
- Multiple Sclerosis
- Tuberous Sclerosis
- Myeloma, Multiple
- Multiple Myeloma
- Myeloma
- Lichen Sclerosis
- Multiple Chemical Sensitivity
- Interferon Beta-1a Injection (Rebif
- Interferon Beta-1a Injection (Avonex
- Twins, Triplets, Multiple Births
- Multiple System Atrophy
- Recessive multiple epiphyseal dysplasia
- Naltrexone
- Hypothermia
- Aspartame
- Cerebral Atrophy
- Juvenile primary lateral sclerosis
- Hives
- Amyotrophic lateral sclerosis, type 2
email this page
print this page
bookmark this page
feedback on this page
